GlassScriptPhysician profile
Brandon Davis Ingram
NPI 1851655229
$3,912.35
in general payments reported to CMS, 2019-2025
27 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,440 · 2020: $326 · 2021: $54.76 · 2022: $200 · 2023: $129 · 2024: $626 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686 · Education: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.86 |
| Education | $206.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,922.36 | 2019-2025 | Da Vinci Surgical System |
| Allergan, INC. | $124.19 | 2019-2020 | |
| Smith+Nephew, INC. | $112.67 | 2019-2025 | Collagenase Santyl |
| Boston Scientific Corporation | $86.42 | 2024 | |
| Ethicon US, LLC | $72.07 | 2019 | |
| Endogastric Solutions, INC | $64.18 | 2023 | Esophyx |
| Tolmar Pharmaceuticals, INC. | $60.02 | 2019-2020 | |
| Covidien LP | $52.12 | 2019-2020 | |
| Edwards Lifesciences Corporation | $48.97 | 2024 | Hemosphere |
| Medtronic, INC. | $44.74 | 2022 | |
| Supernus Pharmaceuticals, INC. | $40.86 | 2019 | |
| Baudax Bio INC. | $38.37 | 2021 | |
| Davol INC. | $24.93 | 2022 | |
| Baxter Healthcare | $24.51 | 2020 | |
| Abbvie INC. | $22.63 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $19.46 | 2020 | |
| Bolder Surgical, LLC | $18.85 | 2022 | |
| Merck Sharp & Dohme LLC | $16.39 | 2021 | |
| Kci USA, INC. | $15.66 | 2022 | |
| Teleflex LLC | $14.56 | 2020 | |
| Polynovo North America LLC | $14.42 | 2025 | Novosorb Btm |
| Mission Pharmacal Company | $14.20 | 2020 | |
| Tela Bio, INC. | $12.47 | 2019 | |
| Bolder Surgical LLC | $12.30 | 2020 | |
| Travere Therapeutics, INC. | $12.29 | 2019 | |
| Microline Surgical INC | $11.69 | 2024 | |
| Integra Lifesciences Corporation | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.